Fig. 7
From: Body mass index-associated molecular characteristics involved in tumor immune and metabolic pathways
The chariotries of immune cell subpopulations in different BMI groups. a The composite expression of each immune cell gene subset in normal, overweight, and obesity patients across all tumor types, with statistical significance calculated by the Kruskal-Wallis rank-sum test. *p value < 0.05, **p value < 0.01, ***p value < 0.001, and ****p value < 0.0001. b The proportion of immune cell-enriched patients in excess weight group, each point represents an immune cell type in each tumor type with the size corresponding to the percent of enriched patients. Filled points corresponding to significant enrichment differences of immune cells between normal and excess weight patients